Riskpilot← Back to searchSign inGet full accessMedirent AB
ABActiveOrg 5593381980Banérgatan 7General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2025
SEK 0
EBITDA margin
—
-126% vs 2024
Equity ratio
34.5%
Financial strength
Net profit 2025
SEK -62K
-129% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -70K | -126% |
| Net profit | SEK -62K | -129% |
| Total assets | SEK 129K | -89% |
| Equity | SEK 45K | -93% |
| Employees | 0 | — |
Legal name
Medirent AB
Org number
5593381980
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk konsultation, utbildning, föreläsningar samt bedriva handel och förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Banérgatan 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 43 | 999 | 819 | 0 |
| Staff expenses | −0 | — | — | −454 | −5 |
| EBITDA | 0 | 29 | 561 | 267 | −70 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 29 | 29 | 561 | 267 | −70 |
| Net financials | 0 | — | — | −0 | 8 |
| Profit before tax | 0 | 29 | 561 | 267 | −62 |
| Tax | 0 | −6 | −116 | −56 | — |
| Net profit | 23 | 23 | 445 | 210 | −62 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 74 | 74 | 897 | 1 124 | 129 |
| Equity | 48 | 48 | 471 | 682 | 45 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 26 | 26 | 426 | 442 | 84 |
| Total debt | 26 | 26 | 426 | 442 | 84 |
EBITDA margin
-6990000.0%
This company
15.8%
Market median
-44240606% vs market
20222025
Equity ratio
34.5%
This company
38.2%
Market median
+10% vs market
20222025
Return on equity
-139.3%
This company
18.4%
Market median
-857% vs market
20222025
Net profit margin
-6201200.0%
This company
8.1%
Market median
-76558125% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
1.90×
This company
0.62×
Market median
-206% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-07-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medirent AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annahita Moghadam | Deputy Board Member | 0 companies |
| Farah Moghadam | Board of Directors | 0 companies |